BioSpace News Archive

[28-April-2020] LUND, Sweden , April 28, 2020 /PRNewswire/ -- Immunovia has today published first quarter interim report for January - March 2020 . It is available on Immunovia’s website . “During Q1 2020, Immunovia worked hard and continued to make great strides towards IMMray™ PanCan-d’s launch and the sales start of the first test for early diagnosis of pancreatic cancer, in spite of

Building on an extensive body of research on the efficacy of BioCell Collagen®, a new published laboratory study finds that daily supplementation with the branded matrix reduced common signs of UVB-induced photoaging compared to the group that did not receive the supplement.

CB Therapeutics is a leading synthetic biotechnology company focused on the research and development of cellular agriculture for the production of cannabinoids, tryptamines and other therapeutics to advance Neuroscience.

The low-cost, scalable solution monitors critical treatment assets - like pharmaceuticals, consumables and medical equipment - from manufacture through delivery.

Quantum Leap Healthcare Collaborative (QLHC), a non-profit organization focused on uniting patient care and research, and sponsor of the adaptive platform I-SPY 2 Trial™, announced today a unique pre-competitive consortium created for an I-SPY COVID Trial to rapidly identify therapies to treat acute respiratory distress syndrome (ARDS) in critically ill COVID-19 patients.

In recognition of Skin Cancer Awareness Month in May, dermatologists remind the public to #PracticeSafeSun to reduce their risk of skin cancer

ClinEdge, a global pharmaceutical and site clinical trial solutions provider, announces a dedicated offering to support clinical development efforts as study landscape shifts due to the COVID-19 crisis.

Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market implant and instrument additions to the ARx Spinal System.

In a letter to Gov. Doug Ducey of Arizona, the Association of American Physicians and Surgeons (AAPS) presents a frequently updated table of studies that report results of treating COVID-19 with the anti-malaria drugs chloroquine (CQ) and hydroxychloroquine (HCQ, Plaquenil®).

F-star Therapeutics Ltd., a clinical-stage biopharmaceutical company focused on transforming the lives of patients with cancer through the development of innovative tetravalent bispecific (mAb2™) antibodies, today announces the publication of preclinical data on the focused, potent and safe immune response shown with FS222 in leading peer-reviewed journal Clinical Cancer Research.